• About Us
  • Contact Us
  • Submit News Release
Tuesday, February 17, 2026
No Result
View All Result
submit news
Oman News Club
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
  • BUSINESS
  • ENERGY
  • FINANCE
  • HEALTHCARE
  • LIFESTYLE
  • REAL ESTATE
  • TECH
  • TRAVEL
  • MIDDLE EAST
  • PRESS RELEASES
No Result
View All Result
Oman News Club
Submit PR
Home PRESS RELEASES

Artificial Intelligence in Pharmaceutical Market size to Reach USD 34.99 Billion by 2031 Amid Rapid Drug Discovery Adoption and Expanding Clinical Applications

by Newsroom Editor
February 17, 2026
Share on FacebookShare on Twitter


Introduction 

According to Mordor Intelligence, the artificial intelligence (AI) in pharmaceutical market size is projected at USD 6.16 billion in 2026, reaching USD 34.99 billion by 2031. The artificial intelligence (AI) in pharmaceutical market forecast indicates strong expansion driven by wider use of data-driven drug discovery, adaptive clinical trials, and AI-supported pharmacovigilance systems. 

The artificial intelligence (AI) in pharmaceutical industry is increasingly integrating machine learning, generative models, and data analytics into research and development workflows. Pharmaceutical companies are redirecting R&D investments toward data-centric platforms that can reduce drug discovery timelines and improve success rates. As regulatory agencies show greater acceptance of AI-based tools, the artificial intelligence (AI) in pharmaceutical market growth continues to accelerate across regions. 

Artificial Intelligence (AI) in Pharmaceutical Market Trends Shaping Industry Adoption 

Rising Cross-Industry Collaborations 

One of the major artificial intelligence (AI) in pharmaceutical market trends is the increase in partnerships between pharmaceutical companies and AI-focused firms. Established drug manufacturers are combining regulatory and clinical expertise with algorithm-driven platforms developed by technology companies. 

Cost and Timeline Pressures in Drug Discovery 

The artificial intelligence (AI) in pharmaceutical industry faces growing pressure to manage research costs and shorten development cycles. AI platforms automate hit identification, molecule optimization, and toxicity prediction.  

Expansion of Adaptive Clinical Trials 

Adaptive trial designs supported by AI tools are gaining wider regulatory acceptance. Algorithms analyze real-time patient data and modify trial parameters to improve enrollment efficiency and outcome accuracy. This development supports the artificial intelligence (AI) in pharmaceutical market size by improving trial performance and reducing delays. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/artificial-intelligence-in-pharmaceutical-market?utm_source=emailwire  

Artificial Intelligence (AI) in Pharmaceutical Market Segmentation 

By Technology 

  • Machine Learning 
  • Generative AI 
  • Natural Language Processing 
  • Computer Vision 
  • Other AI Technologies 

By Offering 

  • Software Platforms 
  • Services 

By Application 

  • Drug Discovery 
  • Clinical Trial Design 
  • Pharmacovigilance 
  • Manufacturing 
  • Sales and Marketing 

By Deployment Mode 

  • Cloud-Based 
  • On-Premise/Edge 
  • Hybrid 

By Geography 

  • North America 
  • Europe 
  • Asia-Pacific 
  • Rest of the World 

Explore Our Full Library of Healthcare Research Report: https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=emailwire  

Artificial Intelligence (AI) in Pharmaceutical Market Competitive Landscape and Key Players 

The artificial intelligence (AI) in pharmaceutical market remains moderately fragmented, with no single company dominating global revenue. Competition is shaped by data access, regulatory validation, and strategic alliances. 

Key Players in the Artificial Intelligence (AI) in Pharmaceutical Market 

  • Deep Genomics 
  • Exscientia 
  • Insilico Medicine 
  • Isomorphic Labs 
  • Recursion Pharmaceuticals 

Conclusion:  

The artificial intelligence (AI) in pharmaceutical market forecast suggests continued strong expansion as drug developers rely more heavily on data-driven research models. From early-stage molecule discovery to post-market safety monitoring, AI tools are becoming embedded across the pharmaceutical lifecycle. 

The artificial intelligence (AI) in pharmaceutical industry is moving toward structured validation frameworks, regulatory clarity, and cross-sector partnerships. While data fragmentation and workforce shortages remain challenges, sustained investment and regulatory endorsement support long-term artificial intelligence (AI) in pharmaceutical market growth. 

Get detailed insights on the artificial intelligence (AI) in pharmaceutical market: https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-pharmaceutical-market?utm_source=emailwire  

Industry Related Reports: 

Medical Equipment Financing Market: The Medical Equipment Financing Market is segmented by financing type, equipment condition, equipment category, end-user, and geography, with forecasts provided in USD. Growth is supported by rising healthcare infrastructure investments, increasing demand for advanced diagnostic systems, and flexible financing models that help providers manage capital expenditure. 

Get more insights: https://www.mordorintelligence.com/industry-reports/medical-equipment-financing-market?utm_source=emailwire 

On-demand Wellness Software Market size: The On-demand Wellness Software Market is estimated at USD 591.39 million in 2026 and is projected to reach USD 891.76 million by 2031, growing at a CAGR of 8.56% during 2026-2031.  

Get more insights: https://www.mordorintelligence.com/industry-reports/on-demand-wellness-software-market?utm_source=emailwire 

Smart Cards in Healthcare Market share: The Smart Cards in Healthcare Market is estimated at USD 2.01 billion in 2026, up from USD 1.79 billion in 2025, and is projected to reach USD 3.55 billion by 2031 at a CAGR of 12.05%. Market growth is fueled by secure patient data management needs, digital health record adoption, and increasing focus on healthcare identity authentication. 

Get more insights: https://www.mordorintelligence.com/industry-reports/smart-cards-in-healthcare-market?utm_source=emailwire 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com
https://www.mordorintelligence.com/ 



Source link

Tags: Artificial Intelligence in Pharmaceutical Market AnalysisArtificial Intelligence in Pharmaceutical Market ShareArtificial Intelligence in Pharmaceutical Market Size
Previous Post

India Life and Non-Life Insurance Market to Reach USD 244.5 Billion, Driven by Retail Expansion, Health Uptake, and Hybrid Distribution Trends

Next Post

Bioinformatics Market to Reach USD 37.03 Billion by 2031 Driven by Expanding Genomics Research and Rising Demand for Precision Medicine

No Result
View All Result

Categories

  • BUSINESS (102)
  • ENERGY (111)
  • FINANCE (112)
  • HEALTHCARE (115)
  • LIFESTYLE (116)
  • MIDDLE EAST (644)
  • PRESS RELEASES (2,971)
  • REAL ESTATE (114)
  • TECH (100)
  • TRAVEL (20)

Recent.

Brain Implants Market to Reach USD 5.64 Billion by 2031 Driven by Rising Neurological Disorders and Expanding Deep Brain Stimulation Adoption

Brain Implants Market to Reach USD 5.64 Billion by 2031 Driven by Rising Neurological Disorders and Expanding Deep Brain Stimulation Adoption

February 17, 2026
Bioinformatics Market to Reach USD 37.03 Billion by 2031 Driven by Expanding Genomics Research and Rising Demand for Precision Medicine

Bioinformatics Market to Reach USD 37.03 Billion by 2031 Driven by Expanding Genomics Research and Rising Demand for Precision Medicine

February 17, 2026
Artificial Intelligence in Pharmaceutical Market size to Reach USD 34.99 Billion by 2031 Amid Rapid Drug Discovery Adoption and Expanding Clinical Applications

Artificial Intelligence in Pharmaceutical Market size to Reach USD 34.99 Billion by 2031 Amid Rapid Drug Discovery Adoption and Expanding Clinical Applications

February 17, 2026

Subscribe to our Newsletter

    Share Us

    Categories

    Categories
    • BUSINESS
    • ENERGY
    • FINANCE
    • HEALTHCARE
    • LIFESTYLE
    • MIDDLE EAST
    • PRESS RELEASES
    • REAL ESTATE
    • TECH
    • TRAVEL

    Recent News

    Recent Posts
    • Brain Implants Market to Reach USD 5.64 Billion by 2031 Driven by Rising Neurological Disorders and Expanding Deep Brain Stimulation Adoption
    • Bioinformatics Market to Reach USD 37.03 Billion by 2031 Driven by Expanding Genomics Research and Rising Demand for Precision Medicine
    • Artificial Intelligence in Pharmaceutical Market size to Reach USD 34.99 Billion by 2031 Amid Rapid Drug Discovery Adoption and Expanding Clinical Applications
    • India Life and Non-Life Insurance Market to Reach USD 244.5 Billion, Driven by Retail Expansion, Health Uptake, and Hybrid Distribution Trends

    About Us

    OmanNews.Club™ reports, publishes and aggregates business, Tech and lifestyle news on Oman the Middle East and the North Africa (MENA). 

    We provide press release distribution to media outlets in Oman, Arab countries and the (MENA) regions. Submit a press release or contact us today.

    Oman News is part of GroupWeb Media Network. @ 2026 GroupWeb Media LLC

    About Us / Contact Us / Submit News Release

    No Result
    View All Result
    • About Us
    • Cart
    • Checkout
    • Contact Us
    • Home
    • My account
    • Shop
    • Submit News Release
    • Test page

    Oman News is part of GroupWeb Media Network. @ 2026 GroupWeb Media LLC